Shanghai, China · Founded 2020 · Privately Held (backing)
Developer of target discovery pharmaceutical technology designed to promote the development of new first-in-class drugs. BioTroy Therapeutics is based in Shanghai, China and was founded in 2020. It has raised $54 million.
Last price · $/share
—
Implied valuation
—
Total raised
$54.0M
Last round
—
Cap table — not yet on record
BioTroy Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BioTroy Therapeutics with a free account
·The complete investor list: 13 names
·Watch BioTroy Therapeutics: the Monday email on marks, rounds and moves
